Oncolys to Initiate PI Trial of Oncolytic Virus Telomelysin “Shortly” in Japan

Oncolys President Yasuo Urata Oncolys BioPharma will shortly initiate administration to the first patient in a domestic PI clinical trial of the oncolytic virus Telomelysin for an expected indication of esophageal cancer, President Yasuo Urata told Jiho in a recent...read more